Author/Authors :
SHAHARYAR King Edward Medical University Lahore , HAFEEZ, M King Edward Medical University Lahore , MASOOD, A.I Nishter Medical College, Multan , PERVEEN, S Institute of Nuclear Medicine and Oncology, Lahore , RASOOL, S C. M. H., Rawalpindi , SHAH, I.H P. M. C., Faisalabad , JAMIL, A Khyber Medical College, Peshawar , SHAHID, ABU BAKER Institute of Nuclear Medicine and Oncology, Lahore , SHABBIR, K King Edward Medical University Lahore , JAVED, ABRAR. A. Nishter Medical College, Multan , MURAD, S Institute of Nuclear Medicine and Oncology, Lahore
Abstract :
Locally advanced breast cancer (LABC) is uncommon in developed countries, where it constitutes only 5% of cases in major centers and less than 20% in other areas. This relative infrequency has seriously limited clinical research and consequently no large-scale studies on treatment of LABC have been reported from the west. It is more common in the developing countries where it constitutes up to 50% of all cases. In Pakistan, according to a population based tumour registry in Karachi, it constitutes 47% of the cases
Keywords :
AC — DOCETAXEL NEO-ADJUVANT , CHEMOTHERAPY FOLLOWED , MODIFIED RADICAL MASTECTOMY , POST-OPERATIVE RADIATION , CHEST WALL , LOCALLY ADVANCED BREAST CANCER
